Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion type Assertion NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_head.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_provenance.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion evidence source_evidence_literature NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_provenance.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion SIO_000772 17606710 NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_provenance.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion wasDerivedFrom befree-20150227 NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_provenance.
- NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_assertion wasGeneratedBy ECO_0000203 NP865390.RA6990sY1h6myb6QaHkbozLzpl3IRwf3CawIPJVs8kxd4130_provenance.